Why the study?
Does BQ-3020 infusion affect renal vascular resistance and nitric oxide release in rat models of hypertension, diabetes, and hypercholesterolemia?
Population
Rat models of hypertension, diabetes mellitus, and hypercholesterolemia
Comparison
BQ-3020 (highly selective ETBR agonist) infusion vs Dahl salt-resistant rats and baseline conditions
Design
Preclinical
Authors
Loading...
Impaired ETBR-NO signaling may drive renal vasoconstriction in salt-sensitive hypertension; leaves open human relevance and therapeutic targeting.
Does BQ-3020 infusion affect renal vascular resistance and nitric oxide release in rat models of hypertension, diabetes, and hypercholesterolemia?
In rat models of arteriosclerosis-related diseases, impaired NO release upon ETBR stimulation is linked to decreased endothelial ETBR expression, highlighting a mechanism for vascular dysfunction.
Kakoki et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: